|
ADGC case-control summary statistics on 7050 samples not included in the IGAP-2013 discovery stage- Hu et al. (2019) |
|
|
|
|
Genetic architecture of subcortical brain structures in 38,851 individuals summary statistics- Satizabal et al. 2019 |
|
|
|
|
ADSP Discovery Case/Control Association Results |
|
|
|
|
Prediction of Psychosis in Alzheimer Disease Summary Statistics - DeMichele-Sweet, et. al. 2021 |
|
|
|
|
Multi-Ethnic Exome Array Study of AD, FTD, and PSP |
|
|
|
|
Genetic analyses of patients with CTE |
|
|
|
|
Exome-wide age-of-onset analysis reveals exonic variants in ERN1 and SPPL2C associated with Alzheimer's disease |
|
|
|
|
CLU, A potential endophenotype for AD: Summary Statistics- Deming et al. (2016) |
|
|
|
|
Alzheimer's Disease Sequencing Project (ADSP) (via DSS) |
|
|
|
|
A fast and robust strategy to remove variant level artifacts in Alzheimer’s Disease Sequencing Project data (Belloy et al. 2022) (via DSS) |
|
|
|
|
Laser Capture and RNA sequencing of Microglia in human brain - Mastroeni et al.(2017) |
|
|
|
|
Alzheimer’s disease single-neuron whole-genome sequencing - Miller 2022 (via DSS) |
|
|
|
|
Identifying Rare Variants That Increase Risk For Alzheimer's Disease |
|
|
124675 |
|
Profiling microglia expression profiles in AD using single-nuclei RNA-seq (via DSS) |
|
|
|
|
GWAS of CLU, A potential endophenotype for Alzheimer's disease |
|
|
6015512 |
|
WashU2 GWAS |
|
|
540469 |
|
MiGA – Microglia Genomic Atlas (via DSS) |
|
|
|
|
Aging, Dementia, and TBI Study |
|
|
|
|
Expression Levels from AD Case-Control Study |
|
|
48803 |
|
MTC GWAS |
|
|
643416 |
